Logo image of CABKA.AS

CABKA (CABKA.AS) Stock Fundamental Analysis

AMS:CABKA - Euronext Amsterdam - NL00150000S7 - Common Stock - Currency: EUR

2.04  -0.06 (-2.86%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CABKA. CABKA was compared to 13 industry peers in the Containers & Packaging industry. CABKA has a bad profitability rating. Also its financial health evaluation is rather negative. CABKA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CABKA has reported negative net income.
In the past year CABKA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CABKA reported negative net income in multiple years.
CABKA had a positive operating cash flow in each of the past 5 years.
CABKA.AS Yearly Net Income VS EBIT VS OCF VS FCFCABKA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.82%, CABKA is doing worse than 83.33% of the companies in the same industry.
The Return On Equity of CABKA (-2.38%) is worse than 83.33% of its industry peers.
CABKA has a Return On Invested Capital of 1.67%. This is amonst the worse of the industry: CABKA underperforms 83.33% of its industry peers.
Industry RankSector Rank
ROA -0.82%
ROE -2.38%
ROIC 1.67%
ROA(3y)-5.44%
ROA(5y)-3.64%
ROE(3y)-13.95%
ROE(5y)-9.74%
ROIC(3y)N/A
ROIC(5y)N/A
CABKA.AS Yearly ROA, ROE, ROICCABKA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 -10 -20 -30 -40

1.3 Margins

The Operating Margin of CABKA (1.22%) is worse than 83.33% of its industry peers.
CABKA's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 46.48%, CABKA is doing good in the industry, outperforming 66.67% of the companies in the same industry.
CABKA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.22%
PM (TTM) N/A
GM 46.48%
OM growth 3Y25.41%
OM growth 5Y-11.27%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.3%
GM growth 5Y-0.97%
CABKA.AS Yearly Profit, Operating, Gross MarginsCABKA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 20 40

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CABKA is destroying value.
Compared to 1 year ago, CABKA has more shares outstanding
The number of shares outstanding for CABKA has been increased compared to 5 years ago.
CABKA has a worse debt/assets ratio than last year.
CABKA.AS Yearly Shares OutstandingCABKA.AS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
CABKA.AS Yearly Total Debt VS Total AssetsCABKA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

CABKA has an Altman-Z score of 1.44. This is a bad value and indicates that CABKA is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.44, CABKA is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
CABKA has a Debt/Equity ratio of 0.65. This is a neutral value indicating CABKA is somewhat dependend on debt financing.
The Debt to Equity ratio of CABKA (0.65) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Altman-Z 1.44
ROIC/WACC0.27
WACC6.12%
CABKA.AS Yearly LT Debt VS Equity VS FCFCABKA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 1.03 indicates that CABKA should not have too much problems paying its short term obligations.
CABKA has a Current ratio of 1.03. This is amonst the worse of the industry: CABKA underperforms 83.33% of its industry peers.
CABKA has a Quick Ratio of 1.03. This is a bad value and indicates that CABKA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.59, CABKA is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.59
CABKA.AS Yearly Current Assets VS Current LiabilitesCABKA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

CABKA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 95.04%, which is quite impressive.
Looking at the last year, CABKA shows a decrease in Revenue. The Revenue has decreased by -5.75% in the last year.
Measured over the past years, CABKA shows a small growth in Revenue. The Revenue has been growing by 5.26% on average per year.
EPS 1Y (TTM)95.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-359.8%
Revenue 1Y (TTM)-5.75%
Revenue growth 3Y13.53%
Revenue growth 5Y5.26%
Sales Q2Q%-11.51%

3.2 Future

The Earnings Per Share is expected to grow by 11.37% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.80% on average over the next years.
EPS Next Y-104.25%
EPS Next 2Y-29.62%
EPS Next 3Y2%
EPS Next 5Y11.37%
Revenue Next Year-10.84%
Revenue Next 2Y-2.46%
Revenue Next 3Y0.9%
Revenue Next 5Y3.8%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CABKA.AS Yearly Revenue VS EstimatesCABKA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
CABKA.AS Yearly EPS VS EstimatesCABKA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 0.4 0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CABKA. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 22.64, CABKA is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CABKA indicates a slightly more expensive valuation: CABKA is more expensive than 75.00% of the companies listed in the same industry.
CABKA's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.10.
Industry RankSector Rank
PE N/A
Fwd PE 22.64
CABKA.AS Price Earnings VS Forward Price EarningsCABKA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CABKA is valued a bit cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.59
CABKA.AS Per share dataCABKA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-29.62%
EPS Next 3Y2%

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.14%, CABKA is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.63, CABKA pays a better dividend. On top of this CABKA pays more dividend than 83.33% of the companies listed in the same industry.
CABKA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 7.14%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of CABKA are negative and hence is the payout ratio. CABKA will probably not be able to sustain this dividend level.
DP-79.1%
EPS Next 2Y-29.62%
EPS Next 3Y2%
CABKA.AS Yearly Income VS Free CF VS DividendCABKA.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M

More info and screens

CABKA

AMS:CABKA (3/7/2025, 7:00:00 PM)

2.04

-0.06 (-2.86%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners53.31%
Ins Owner ChangeN/A
Market Cap83.03M
Analysts85.45
Price Target4.69 (129.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.14%
Yearly Dividend0.05
Dividend Growth(5Y)N/A
DP-79.1%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.83%
PT rev (3m)-9.8%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-50%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.41%
Revenue NY rev (3m)-0.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 22.64
P/S 0.42
P/FCF N/A
P/OCF 5.29
P/B 1.28
P/tB 1.33
EV/EBITDA 7.59
EPS(TTM)-0.06
EYN/A
EPS(NY)0.09
Fwd EY4.42%
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)0.39
OCFY18.89%
SpS4.84
BVpS1.59
TBVpS1.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.82%
ROE -2.38%
ROCE 2.23%
ROIC 1.67%
ROICexc 1.75%
ROICexgc 1.8%
OM 1.22%
PM (TTM) N/A
GM 46.48%
FCFM N/A
ROA(3y)-5.44%
ROA(5y)-3.64%
ROE(3y)-13.95%
ROE(5y)-9.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y24.53%
ROICexcg growth 5Y-13.72%
ROICexc growth 3Y24.08%
ROICexc growth 5Y-13.56%
OM growth 3Y25.41%
OM growth 5Y-11.27%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.3%
GM growth 5Y-0.97%
F-Score4
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Debt/EBITDA 2
Cap/Depr 145%
Cap/Sales 13.86%
Interest Coverage 0.54
Cash Conversion 73.93%
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 0.59
Altman-Z 1.44
F-Score4
WACC6.12%
ROIC/WACC0.27
Cap/Depr(3y)138.21%
Cap/Depr(5y)112.92%
Cap/Sales(3y)12.93%
Cap/Sales(5y)11.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)95.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-359.8%
EPS Next Y-104.25%
EPS Next 2Y-29.62%
EPS Next 3Y2%
EPS Next 5Y11.37%
Revenue 1Y (TTM)-5.75%
Revenue growth 3Y13.53%
Revenue growth 5Y5.26%
Sales Q2Q%-11.51%
Revenue Next Year-10.84%
Revenue Next 2Y-2.46%
Revenue Next 3Y0.9%
Revenue Next 5Y3.8%
EBIT growth 1Y173.38%
EBIT growth 3Y42.37%
EBIT growth 5Y-6.61%
EBIT Next Year225.24%
EBIT Next 3Y64.99%
EBIT Next 5Y40.06%
FCF growth 1Y-524.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.33%
OCF growth 3Y17.49%
OCF growth 5Y8.25%